Cite
HARVARD Citation
Khaki, A. et al. (2023). Adjuvant checkpoint inhibitor trials: Is disease-free survival an appropriate endpoint?. Journal of cancer policy. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Khaki, A. et al. (2023). Adjuvant checkpoint inhibitor trials: Is disease-free survival an appropriate endpoint?. Journal of cancer policy. p. . [Online].